An Open-label, Fixed-sequence, Single-centre Phase I Study to Assess the Effect of Ketoconazole on the Pharmacokinetics of AZD5069 After Oral Administration of a Single Dose AZD5069 to Healthy Male Volunteers
Phase of Trial: Phase I
Latest Information Update: 08 Jan 2016
At a glance
- Drugs AZD 5069 (Primary) ; Ketoconazole
- Indications Asthma
- Focus Pharmacokinetics
- Sponsors AstraZeneca
- 01 Feb 2013 Status changed from recruiting to completed as reported by ClinicalTrials.gov record.
- 03 Jan 2013 New trial record
- 01 Dec 2012 Status changed from not yet recruiting to recruiting as reported by ClinicalTrials.gov record.